KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $189.5 million.

  • Charles River Laboratories International's Other Non-Current Liabilities fell 1994.64% to $189.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $189.5 million, marking a year-over-year decrease of 1994.64%. This contributed to the annual value of $195.2 million for FY2024, which is 1253.59% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Other Non-Current Liabilities of $189.5 million as of Q3 2025, which was down 1994.64% from $185.2 million recorded in Q2 2025.
  • Charles River Laboratories International's Other Non-Current Liabilities' 5-year high stood at $242.9 million during Q4 2021, with a 5-year trough of $172.5 million in Q3 2023.
  • For the 5-year period, Charles River Laboratories International's Other Non-Current Liabilities averaged around $205.2 million, with its median value being $196.4 million (2025).
  • In the last 5 years, Charles River Laboratories International's Other Non-Current Liabilities plummeted by 2801.5% in 2022 and then skyrocketed by 3718.51% in 2024.
  • Charles River Laboratories International's Other Non-Current Liabilities (Quarter) stood at $242.9 million in 2021, then dropped by 28.02% to $174.8 million in 2022, then increased by 27.67% to $223.2 million in 2023, then dropped by 12.54% to $195.2 million in 2024, then dropped by 2.95% to $189.5 million in 2025.
  • Its Other Non-Current Liabilities was $189.5 million in Q3 2025, compared to $185.2 million in Q2 2025 and $196.4 million in Q1 2025.